BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25808111)

  • 1. Expression of nuclear matrix proteins binding matrix attachment regions in prostate cancer. PARP-1: New player in tumor progression.
    Barboro P; Ferrari N; Capaia M; Petretto A; Salvi S; Boccardo S; Balbi C
    Int J Cancer; 2015 Oct; 137(7):1574-86. PubMed ID: 25808111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nuclear matrix proteins binding to matrix attachment regions (Mars) in prostate cancer cell differentiation.
    Barboro P; Repaci E; D'Arrigo C; Balbi C
    PLoS One; 2012; 7(7):e40617. PubMed ID: 22808207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Expression of Nuclear Matrix Proteins Binding Matrix Attachment Regions in Prostate Cancer. PARP-1: New Player in Tumor Progression.
    Atala A
    J Urol; 2016 Mar; 195(3):801. PubMed ID: 26887755
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.
    Gui B; Gui F; Takai T; Feng C; Bai X; Fazli L; Dong X; Liu S; Zhang X; Zhang W; Kibel AS; Jia L
    Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14573-14582. PubMed ID: 31266892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenoxodiol inhibits growth of metastatic prostate cancer cells.
    Aguero MF; Venero M; Brown DM; Smulson ME; Espinoza LA
    Prostate; 2010 Aug; 70(11):1211-21. PubMed ID: 20564423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual roles of PARP-1 promote cancer growth and progression.
    Schiewer MJ; Goodwin JF; Han S; Brenner JC; Augello MA; Dean JL; Liu F; Planck JL; Ravindranathan P; Chinnaiyan AM; McCue P; Gomella LG; Raj GV; Dicker AP; Brody JR; Pascal JM; Centenera MM; Butler LM; Tilley WD; Feng FY; Knudsen KE
    Cancer Discov; 2012 Dec; 2(12):1134-49. PubMed ID: 22993403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caught in the act: binding of Ku and PARP to MARs reveals novel aspects of their functional interaction.
    Galande S; Kohwi-Shigematsu T
    Crit Rev Eukaryot Gene Expr; 2000; 10(1):63-72. PubMed ID: 10813395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for prostate cancer by targeting poly(ADP-ribose) polymerase.
    Trofimova I; Dimtchev A; Jung M; Rosenthal D; Smulson M; Dritschilo A; Soldatenkov V
    Cancer Res; 2002 Dec; 62(23):6879-83. PubMed ID: 12460902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of the nuclear matrix in the early stages of rat liver carcinogenesis: identification of differentially expressed and MAR-binding proteins.
    Barboro P; D'Arrigo C; Repaci E; Bagnasco L; Orecchia P; Carnemolla B; Patrone E; Balbi C
    Exp Cell Res; 2009 Jan; 315(2):226-39. PubMed ID: 19000672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human poly (ADP-ribose) polymerase 1 in Saccharomyces cerevisiae: Effect on survival, homologous recombination and identification of genes involved in intracellular localization.
    La Ferla M; Mercatanti A; Rocchi G; Lodovichi S; Cervelli T; Pignata L; Caligo MA; Galli A
    Mutat Res; 2015 Apr; 774():14-24. PubMed ID: 25779917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial DNA depletion reduces PARP-1 levels and promotes progression of the neoplastic phenotype in prostate carcinoma.
    Moro L; Arbini AA; Marra E; Greco M
    Cell Oncol; 2008; 30(4):307-22. PubMed ID: 18607066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of PARP-1 and its active polymer PAR in prostate cancer and benign prostatic hyperplasia in Chinese patients.
    Wu W; Zhu H; Liang Y; Kong Z; Duan X; Li S; Zhao Z; Yang D; Zeng G
    Int Urol Nephrol; 2014 Jul; 46(7):1345-9. PubMed ID: 24436031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-resistant prostate cancer cell line, PC3.
    Ding H; Sun Y; Hou Y; Li L
    Urol Oncol; 2014 Jul; 32(5):720-6. PubMed ID: 24837011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatin loops are selectively anchored using scaffold/matrix-attachment regions.
    Heng HH; Goetze S; Ye CJ; Liu G; Stevens JB; Bremer SW; Wykes SM; Bode J; Krawetz SA
    J Cell Sci; 2004 Mar; 117(Pt 7):999-1008. PubMed ID: 14996931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP-1 expression in the mouse is controlled by an autoregulatory loop: PARP-1 binding to an upstream S/MAR element and to a novel recognition motif in its promoter suppresses transcription.
    Vidaković M; Gluch A; Qiao J; Oumard A; Frisch M; Poznanović G; Bode J
    J Mol Biol; 2009 May; 388(4):730-50. PubMed ID: 19303024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of poly(ADP-ribose) polymerase inhibition by ABT-888 in patients with refractory solid tumors and lymphomas.
    Yang SX; Kummar S; Steinberg SM; Murgo AJ; Gutierrez M; Rubinstein L; Nguyen D; Kaur G; Chen AP; Giranda VL; Tomaszewski JE; Doroshow JH;
    Cancer Biol Ther; 2009 Nov; 8(21):2004-9. PubMed ID: 19823047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.
    Martin-Oliva D; Aguilar-Quesada R; O'valle F; Muñoz-Gámez JA; Martínez-Romero R; García Del Moral R; Ruiz de Almodóvar JM; Villuendas R; Piris MA; Oliver FJ
    Cancer Res; 2006 Jun; 66(11):5744-56. PubMed ID: 16740713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased PARP-1 levels in nuclear matrix isolated from heat shock treated rat liver.
    Zaalishvili G; Zaldastanishvili E; Karapetian M; Zaalishvili T
    Biochemistry (Mosc); 2012 Jan; 77(1):105-10. PubMed ID: 22339640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PJ-34 inhibits PARP-1 expression and ERK phosphorylation in glioma-conditioned brain microvascular endothelial cells.
    Motta C; D'Angeli F; Scalia M; Satriano C; Barbagallo D; Naletova I; Anfuso CD; Lupo G; Spina-Purrello V
    Eur J Pharmacol; 2015 Aug; 761():55-64. PubMed ID: 25934569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.
    Peralta-Leal A; Rodríguez-Vargas JM; Aguilar-Quesada R; Rodríguez MI; Linares JL; de Almodóvar MR; Oliver FJ
    Free Radic Biol Med; 2009 Jul; 47(1):13-26. PubMed ID: 19362586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.